James Lind Institute began as a patient community for Danish diabetics. Soon after, we expanded and included patients suffering from multiple sclerosis and cardiovascular diseases.
After establishing our way of connecting patients and clinical trials to develop better treatments, we took our model to the UK and Sweden.
We hope to increase the numbers of researchers and types of patients we bring together. Our goal is to create strong, valuable patient communities throughout Europe.